Scolaris Content Display Scolaris Content Display

Interventions for childhood apraxia of speech

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Murray 2015 {published data only}

Murray E, McCabe P, Ballard KJ. A randomized controlled trial for children with childhood apraxia of speech comparing rapid syllable transition treatment and the Nuffield Dyspraxia Programme ‐Third Edition. Journal of Speech, Language, and Hearing Research 2015;58(3):669‐86. [DOI: 10.1044/2015_JSLHR‐S‐13‐0179; PUBMED: 25807891]CENTRAL
Murray E. (Faculty of Health Sciences, The University of Sydney, Lidcombe, Australia). [personal communication]. Conversation with: A Morgan (Murdoch Children's Research Institute, Melbourne, Australia) 13 August 2015. CENTRAL

References to studies excluded from this review

Baas 2008 {published data only}

Baas BS, Strand EA, LM Elmer, Barbaresi WJ. Treatment of severe childhood apraxia of speech in a 12‐year‐old male with CHARGE association. Journal of Medical Speech‐language Pathology 2008;16(4):181‐90. CENTRAL

Ballard 2010 {published data only}

Ballard KJ, Robin DA, McCabe P, McDonald J. A treatment for dysprosody in childhood apraxia of speech. Journal of Speech, Language, and Hearing Research 2010;53(5):1227‐45. [DOI: 10.1044/1092‐4388(2010/09‐0130); PUBMED: 20798323]CENTRAL

Beathard 2008 {published data only}

Beathard B, Krout RE. A music therapy clinical case study of a girl with childhood apraxia of speech: finding Lily's voice. Arts in Psychotherapy 2008;35(2):107‐16. [DOI: 10.1016/j.aip.2008.01.004]CENTRAL

Binger 2007 {published data only}

Binger C, Light J. The effect of aided AAC modeling on the expression of multi‐symbol messages by preschoolers who use AAC. Augmentative and Alternative Communication 2007;23(1):30‐43. [DOI: 10.1080/07434610600807470; PUBMED: 17364486]CENTRAL

Binger 2008 {published data only}

Binger C, Light J. The morphology and syntax of individuals who use AAC: research review and implications for effective practice. Augmentative and Alternative Communications 2008;24(2):123‐38. [DOI: 10.1080/07434610701830587; PUBMED: 18465366]CENTRAL

Binger 2011 {published data only}

Binger C, Maguire‐Marshall M, Kent‐Walsh J. Using aided AAC models, recasts, and contrastive targets to teach grammatical morphemes to children who use AAC. Journal of Speech, Language, and Hearing Research 2011;54(1):160‐76. [DOI: 10.1044/1092‐4388(2010/09‐0163); PUBMED: 20719874]CENTRAL

Bornman 2001 {published data only}

Bornman J, Alant E, Meiring E. The use of a digital voice output device to facilitate language development in a child with developmental apraxia of speech: a case study. Disability and Rehabilitation 2001;23(14):623‐34. [PUBMED: 11697460]CENTRAL

Bose 2001 {published data only}

Bose A, Square PA, Schlosser R, van Lieshout P. Effects of PROMPT therapy on speech motor function in a person with aphasia and apraxia of speech. Aphasiology 2001;15(8):767‐85. [DOI: 10.1080/02687040143000186]CENTRAL

Carter 2004 {published data only}

Carter P, Edwards S. EPG therapy for children with long‐standing speech disorders: predictions and outcomes. Clinical Linguistics and Phonetics 2004;18(6‐8):359‐72. [PUBMED: 15573477]CENTRAL

Chappell 1973 {published data only}

Chappell GE. Childhood verbal apraxia and its treatment. Journal of Speech and Hearing Disorders 1973;38(3):362‐8. [PUBMED: 4721796]CENTRAL

Culp 1989 {published data only}

Culp DM. Developmental apraxia and augmentative or alternative communication ‐ a case example. Augmentative and Alternative Communication 1989;5(1):27‐34. [DOI: 10.1080/07434618912331274936]CENTRAL

Cumley 1999 {published data only}

Cumley GD, Swanson S. Augmentative and alternative communication options for children with developmental apraxia of speech: three case studies. Augmentative and Alternative Communication 1999;15(2):110‐25. [DOI: 10.1080/07434619912331278615]CENTRAL

Dale 2013 {published data only}

Dale PS, Hayden DA. Treating speech subsystems in childhood apraxia of speech with tactual input: the PROMPT approach. American Journal of Speech‐language Pathology 2013;22(4):644‐61. [DOI: 10.1044/1058‐0360(2013/12‐0055); PUBMED: 23813194]CENTRAL

Daly 1972 {published data only}

Daly DA, Cantrell RP, Cantrell ML, Aman LA. Structure speech therapy contingencies with an oral apraxic child. Journal of Speech and Hearing Disorders 1972;37(1):22‐32. [DOI: 10.1044/jshd.3701.22]CENTRAL

Dworkin 1988 {published data only}

Dworkin JP, Abkarian GG, John DF. Apraxia of speech: the effectiveness of a treatment regimen. Journal of Speech and Hearing Disorders 1988;53(3):280‐94. [PUBMED: 3398481]CENTRAL

Edeal 2011 {published data only}

Edeal DM, Gildersleeve‐Neumann CE. The importance of production frequency in therapy for childhood apraxia of speech. American Journal of Speech‐language Pathology 2011;20(2):95‐110. [DOI: 10.1044/1058‐0360(2011/09‐0005); PUBMED: 21330650]CENTRAL

Forrest 2001 {published data only}

Forrest K, Elbert M. Treatment for phonologically disordered children with variable substitution patterns. Clinical Linguistics & Phonetics 2001;15(1‐2):41‐5. [DOI: 10.3109/02699200109167628; PUBMED: 21269096]CENTRAL

Groenen 1996 {published data only}

Groenen P, Maassen B, Crul T, Thoonen G. The specific relation between perception and production errors for place of articulation in developmental apraxia of speech. Journal of Speech and Hearing Research 1996;39(3):468‐82. [PUBMED: 8783127]CENTRAL

Hadar 1984 {published data only}

Hadar U, Twiston‐Davies R, Steiner TJ, Rose FC. A psychomotor approach to improving speech by modulating suprasegmental control in motor dysphasia and articulatory apraxia. Advances in Neurology 1984;42:337‐51. [PUBMED: 6507181]CENTRAL

Hall 1989 {published data only}

Hall PK. The occurrence of developmental apraxia of speech in a mild articulation disorder: a case study. Journal of Communication Disorders 1989;22(4):265‐76. [PUBMED: 2794108]CENTRAL

Hall 1990 {published data only}

Hall PK, Hardy JC, LaVelle WE. A child with signs of developmental apraxia of speech with whom a palatal lift prosthesis was used to manage palatal dysfunction. Journal of Speech and Hearing Disorders 1990;55(3):454‐60. [PUBMED: 2381187]CENTRAL

Harris 1996 {published data only}

Harris L, Doyle ES, Haaf R. Language treatment approach for users of AAC: experimental single‐subject investigation. Augmentative and Alternative Communication (Baltimore, Md. : 1985) 1996;12(4):230‐43. [DOI: 10.1080/07434619612331277698]CENTRAL

Hayden 2006 {published data only}

Hayden D. The PROMPT model: use and application for children with mixed phonological‐motor impairment. Advances in Speech Language Pathology 2006;8(3):265‐81. [DOI: 10.1080/14417040600861094]CENTRAL

Head 1975 {published data only}

Head DG, Smith D. Speech remediation of children involved in two different physical education programs. Perceptual and Motor Skills 1975;40(1):261‐2. [DOI: 10.2466/pms.1975.40.1.261; PUBMED: 1118271]CENTRAL

Helfrich‐Miller 1994 {published data only}

Helfrich‐Miller KR. A clinical perspective: melodic intonation therapy for developmental apraxia. Clinics in Communication Disorders 1994;4(3):175‐82. [PUBMED: 7994292]CENTRAL

Iuzzini 2010 {published data only}

Iuzzini J, Forrest K. Evaluation of a combined treatment approach for childhood apraxia of speech. Clinical Linguistics and Phonetics 2010;24(4‐5):335‐45. [DOI: 10.3109/02699200903581083; PUBMED: 20345262]CENTRAL

Jaroma 1984 {published data only}

Jaroma M, Danner P, Koivuniemi E. Sensory integrative therapy and speech therapy for improving the perceptual motor skills and speech articulation of a dyspractic boy. Folia Phoniatrica 1984;36(6):261‐6. [DOI: 10.1159/000265753]CENTRAL

Kadis 2014 {published data only}

Kadis DS, Goshulak D, Namasivayam A, Pukonen M, Kroll R, De Nil LF, et al. Cortical thickness in children receiving intensive therapy for idiopathic apraxia of speech. Brain Topography 2014;27(2):240‐7. [DOI: 10.1007/s10548‐013‐0308‐8; PMC3921462; PUBMED: 23974724]CENTRAL

Katz 2006 {published data only}

Katz WF, Bharadwaj SV, Stettler MP. Influences of electromagnetic articulography sensors on speech produced by healthy adults and individuals with aphasia and apraxia. Journal of Speech, Language, and Hearing Research 2006;49(3):645‐59. [DOI: 10.1044/1092‐4388(2006/047); PUBMED: 16787902]CENTRAL

King 2013 {published data only}

King AM, Hengst JA, DeThorne LS. Severe speech sound disorders: an integrated multimodal intervention. Language, Speech, and Hearing Services in Schools 2013;44(2):195‐210. [DOI: 10.1044/0161‐1461(2012/12‐0023); PUBMED: 23633644]CENTRAL

Kingston 1987 {published data only}

Kingston LM, Rosenthal JB. Oral stereognosis in children with disordered articulation: measurement issues, and a treatment study. Australian Journal of Human Communication Disorders 1987;15(1):1‐14. [DOI: 10.3109/asl2.1987.15.issue‐1.01]CENTRAL

Klick 1985 {published data only}

Klick SL. Adapted cuing technique for use in treatment of dyspraxia. Language, Speech, and Hearing Services in Schools 1985;16:256‐9. [DOI: 10.1044/0161‐1461.1604.256]CENTRAL

Krauss 1982 {published data only}

Krauss T, Galloway H. Melodic intonation therapy with language delayed apraxic children. Journal of Music Therapy 1982;19(2):102‐13. [DOI: 10.1093/jmt/19.2.102]CENTRAL

Lagasse 2012 {published data only}

Lagasse B. Evaluation of melodic intonation therapy for developmental apraxia of speech. Music Therapy Perspectives 2012;30(1):49‐55. [DOI: 10.1093/mtp/30.1.49]CENTRAL

Lozano 1978 {published data only}

Lozano RA, Dreyer DE. Some effects of delayed auditory feedback on dyspraxia of speech. Journal of Communication Disorders 1978;11(5):407‐15. [PUBMED: 730833]CENTRAL

Lüke 2016 {published data only}

Lüke C. Impact of speech‐generating devices on the language development of a child with childhood apraxia of speech: a case study. Disability and Rehabilitation. Assistive Technology 2016;11(1):80‐8. [DOI: 10.3109/17483107.2014.913715; PUBMED: 24773213]CENTRAL

Lundeborg 2007 {published data only}

Lundeborg I, McAllister A. Treatment with a combination of intra‐oral sensory stimulation and electropalatography in a child with severe developmental dyspraxia. Logopedics, Phoniatrics, Vocology 2007;32(2):71‐9. [DOI: 10.1080/14015430600852035; PUBMED: 17613788]CENTRAL

Maas 2012a {published data only}

Maas E, Butalla CE, Farinella KA. Feedback frequency in treatment for childhood apraxia of speech. American Journal of Speech‐language Pathology 2012;21(3):239‐57. [DOI: 10.1044/1058‐0360(2012/11‐0119); PUBMED: 22442284]CENTRAL

Maas 2012b {published data only}

Maas E, Farinella KA. Random versus blocked practice in treatment for childhood apraxia of speech. Journal of Speech, Language, and Hearing Research 2012;55(2):561‐78. [DOI: 10.1044/1092‐4388(2011/11‐0120); PUBMED: 22207698]CENTRAL

Martikainen 2011 {published data only}

Martikainen A‐L, Korpilahti P. Intervention for childhood apraxia of speech: a single‐case study. Child Language Teaching and Therapy 2011;27(1):9‐20. [DOI: 10.1177/0265659010369985]CENTRAL

Martin 2016 {published data only}

Martin MK, Wright LE, Perry S, Cornett D, Schraeder M, Johnson JT. Children with developmental verbal dyspraxia: changes in articulation and perceived resilience with intensive multimodal intervention. Child Language Teaching and Therapy 2016;32(3):261‐75. [DOI: 10.1177/0265659015615924]CENTRAL

McCabe 2014 {published data only}

McCabe P, Macdonald‐D'Silva AG, van Rees LJ, Ballard KJ, Arciuli J. Orthographically sensitive treatment for dysprosody in children with childhood apraxia of speech using ReST intervention. Developmental Neurorehabilitation 2014;17(2):137‐46. [DOI: 10.3109/17518423.2014.906002; PUBMED: 24694312]CENTRAL

McNeill 2009a {published data only}

McNeill BC, Gillon GT, Dodd B. Phonological awareness and early reading development in childhood apraxia of speech (CAS). International Journal of Language & Communication Disorders / Royal College of Speech & Language Therapists 2009;44(2):175‐92. [DOI: 10.1080/13682820801997353; PUBMED: 19234970]CENTRAL

McNeill 2009b {published data only}

McNeill BC, Gillon GT, Dodd B. A longitudinal case study of the effects of an integrated phonological awareness program for identical twin boys with childhood apraxia of speech (CAS). International Journal of Speech‐language Pathology 2009;11(6):482‐95. [DOI: 10.3109/17549500902842583; PUBMED: 21271925 ]CENTRAL

McNeill 2010 {published data only}

McNeill BC, Gillon GT, Dodd B. The longer term effects of an integrated phonological awareness intervention for children with childhood apraxia of speech. Asia Pacific Journal of Speech, Language, and Hearing 2010;13(3):145‐61. [DOI: 10.1179/136132810805335074]CENTRAL

Morgan Barry 1995 {published data only}

Morgan Barry R. The relationship between dysarthria and verbal dyspraxia in children: a comparative study using profiling and instrumental analyses. Clinical Linguistics & Phonetics 1995;9(4):277‐309. [DOI: 10.3109/02699209508985338]CENTRAL

Moriarty 2006 {published data only}

Moriarty BC, Gillon GT. Phonological awareness intervention for children with childhood apraxia of speech. International Journal of Language & Communication Disorders / Royal College of Speech & Language Therapists 2006;41(6):713‐34. [DOI: 10.1080/13682820600623960; PUBMED: 17079224]CENTRAL

Namasivayam 2013 {published data only}

Namasivayam AK, Pukonen M, Goshulak D, Yu VY, Kadis DS, Kroll R, et al. Relationship between speech motor control and speech intelligibility in children with speech sound disorders. Journal of Communication Disorders 2013;46(3):264‐80. [DOI: 10.1016/j.jcomdis.2013.02.003; PUBMED: 23628222]CENTRAL

Namasivayam 2015 {published data only}

Namasivayam A, Pukonen M, Hard J, Jahnke R, Kearney E, Kroll R, et al. Motor speech treatment protocol for developmental motor speech disorders. Developmental Neurorehabilitation 2015;18(5):296‐303. [DOI: 10.3109/17518423.2013.832431; PUBMED: 24088085]CENTRAL

Preston 2013 {published data only}

Preston JL, Brick N, Landi N. Ultrasound biofeedback treatment for persisting childhood apraxia of speech. American Journal of Speech‐language Pathology 2013;22(4):627‐43. [DOI: 10.1044/1058‐0360(2013/12‐0139); PUBMED: 23813207]CENTRAL

Preston 2016 {published data only}

Preston JL, Leece MC, Maas E. Intensive treatment with ultrasound visual feedback for speech sound errors in childhood apraxia. Frontiers in Human Neuroscience 2016;10:440. [DOI: 10.3389/fnhum.2016.00440; PMC5003919; PUBMED: 27625603]CENTRAL

Preston 2017 {published data only}

Preston JL, Leece MC, Maas E. Motor‐based treatment with and without ultrasound feedback for residual speech‐sound errors. International Journal of Language and Communication Disorders 2017;52(1):80‐94. [DOI: 10.1111/1460‐6984.12259; PMC5156595; PUBMED: 27296780]CENTRAL

Ray 2003 {published data only}

Ray J. Effects of orofacial myofunctional therapy on speech intelligibility in individuals with persistent articulatory impairments. International Journal of Orofacial Myology 2003;29:5‐14. [PUBMED: 14689652]CENTRAL

Richardson 2004 {published data only}

Richardson AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2004;70(4):383‐90. [DOI: 10.1016/j.plefa.2003.12.020; PUBMED: 15041031]CENTRAL

Rosenbek 1974 {published data only}

Rosenbek J, Hansen R, Baughman CH, Lemme M. Treatment of developmental apraxia of speech: a case study. Language, Speech, and Hearing Services in Schools 1974;5:13‐22. [DOI: 10.1044/0161‐1461.0501.13]CENTRAL

Rosenthal 1994 {published data only}

Rosenthal JB. Rate control therapy for developmental apraxia of speech. Clinics in Communication Disorders 1994;4(3):190‐200. [PUBMED: 7994294]CENTRAL

Skelton 2014 {published data only}

Skelton SL, Hagopian AL. Using randomized variable practice in the treatment of childhood apraxia of speech. American Journal of Speech‐language Pathology 2014;23(4):599‐611. [DOI: 10.1044/2014_AJSLP‐12‐0169; MEDLINE: 25017177]CENTRAL

Square 1994 {published data only}

Square PA. Treatment approaches for developmental apraxia of speech. Clinics in Communication Disorders 1994;4(3):151‐61. [PUBMED: 7994290]CENTRAL

Stokes 2010 {published data only}

Stokes SF, Griffiths R. The use of facilitative vowel contexts in the treatment of post‐alveolar fronting: a case study. International Journal of Language & Communication Disorders / Royal College of Speech & Language Therapists 2010;45(3):368‐80. [DOI: 10.3109/13682820903094737; PUBMED: 20144008]CENTRAL

Strand 2000 {published data only}

Strand EA, Debertine P. The efficacy of integral stimulation intervention with developmental apraxia of speech. Journal of Medical Speech‐language Pathology 2000;8(4):295‐300. [www.researchgate.net/publication/286964810_The_efficacy_of_integral_stimulation_intervention_with_developmental_apraxia_of_speech]CENTRAL

Strand 2006 {published data only}

Strand EA, Stoeckel R, Baas B. Treatment of severe childhood apraxia of speech: a treatment efficacy study. Journal of Medical Speech‐language Pathology 2006;14(4):297‐307. [psycnet.apa.org/record/2006‐22884‐013]CENTRAL

Thomas 2014 {published data only}

Thomas DC, McCabe P, Ballard KJ. Rapid Syllable Transitions (ReST) treatment for childhood apraxia of speech: the effect of lower dose‐frequency. Journal of Communication Disorders 2014;51:29‐42. [DOI: 10.1016/j.jcomdis.2014.06.004; PUBMED: 25052390]CENTRAL

Thomas 2016 {published data only}

Thomas DC, McCabe P, Ballard KJ, Lincoln M. Telehealth delivery of Rapid Syllable Transitions (ReST) treatment for childhood apraxia of speech. International Journal of Language & Communication Disorders 2016;51(6):654‐71. [DOI: 10.1111/1460‐6984.12238; PUBMED: 27161038]CENTRAL

Tierney 2016 {published data only}

Tierney CD, Pitterle K, Kurtz M, Nakhla M, Todorow C. Bridging the gap between speech and language: using multimodal treatment in a child with apraxia. Pediatrics 2016;138(3):e20160007. [DOI: 10.1542/peds.2016‐0007; PUBMED: 27492818]CENTRAL

Vashdi 2013 {published data only}

Vashdi E. Using VML (verbal motor learning) method techniques in treatment of prosody disorder due to childhood apraxia of speech: a case study. International Journal of Child Health and Human Development 2013;6(2):255‐60. [www.novapublishers.com/catalog/product_info.php?products_id=52658]CENTRAL

Vashdi 2014 {published data only}

Vashdi E. The influence of initial phoneme cue technique on word formation: a case study of a child with apraxia of speech and autism. International Journal of Child Health and Human Development 2014;7(2):197‐203. [www.novapublishers.com/catalog/product_info.php?products_id=53974]CENTRAL

Velleman 1994 {published data only}

Velleman SL, Strand K. Developmental verbal dyspraxia. In: Bernthal JE, Bankson NW editor(s). Child Phonology: Characteristics, Assessment, and Intervention with Special Populations. New York (NY): Thieme, 1994:110‐39. [ISBN 0‐86577‐502‐8]CENTRAL

Yoss 1974 {published data only}

Yoss KA, Darley FL. Developmental apraxia of speech in children with defective articulation. Journal of Speech and Hearing Research 1974;17(3):399‐416. [PUBMED: 4421901]CENTRAL

Zaretsky 2010 {published data only}

Zaretsky E, Velleman SL, Curro K. Through the magnifying glass: underlying literacy deficits and remediation potential in childhood apraxia of speech. International Journal of Speech‐language Pathology 2010;12(1):58‐68. [PUBMED: 20380250]CENTRAL

ASHA 2007

American Speech‐Language‐Hearing Association (ASHA). Technical Report. Childhood Apraxia of Speech: Ad Hoc Committee on Apraxia of Speech in Children. www.asha.org/policy/TR2007‐00278/ (accessed 20 April 2018).

Chumpelik 1984

Chumpelik D. The PROMPT system of therapy: theoretical framework and applications for developmental apraxia of speech. Seminars in Speech and Language 1984;5(2):139‐56. [DOI: 10.1055/s‐0028‐1085172]

Crosbie 2005

Crosbie S, Holm A, Dodd B. Intervention for children with severe speech disorder: a comparison of two approaches. International Journal of Language and Communication Disorders 2005;40(4):469‐71. [DOI: 10.1080/13682820500126049; PUBMED: 16195201]

Davis 2005

Davis BL, Jacks A, Marquardt TP. Vowel patterns in developmental apraxia of speech: three longitudinal case studies. Clinical Linguistics and Phonetics 2005;19(4):249‐74. [DOI: 10.1080/02699200410001695367; PUBMED: 16019775]

Delaney 2004

Delaney AL, Kent RD. Developmental profiles of children diagnosed with apraxia of speech. Annual Convention of the American Speech‐Language‐Hearing Association; 2004 Nov 18‐20; Philadelphia (PA). 2004.

Dodd 2006

Dodd B, Hua Z, Crosbie S, Holm A, Ozanne A. DEAP: Diagnostic Evaluation of Articulation and Phonology. San Antonio (TX): PsychCorp of Harcourt Assessment, 2006.

Dodd 2008

Dodd B, Crosbie S, McIntosh B, Holm A, Harvey C, Liddy M, et al. The impact of selecting difference contrasts in phonological therapy. International Journal of Speech‐Language Pathology 2008;10(5):334‐45. [DOI: 10.1080/14417040701732590; PUBMED: 20840033]

Eadie 2015

Eadie P, Morgan A, Ukoumunne OC, Ttofari Eecen K, Wake M, Reilly S. Speech sound disorder at 4 years: prevalence, comorbidities, and predictors in a community cohort of children. Developmental Medicine and Child Neurology 2015;57(6):578‐84. [DOI: 10.1111/dmcn.12635; PUBMED: 25403868]

Egger 1997

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34. [DOI: 10.1136/bmj.315.7109.629; PMC2127453; PUBMED: 9310563]

Eising 2018

Eising E, Carrion‐Castillo A, Vino A, Strand EA, Jakielski KJ, Scerri TS, et al. A set of regulatory genes co‐expressed in embryonic human brain is implicated in disrupted speech development. Molecular Psychiatry 2018 Feb 20 [Epub ahead of print]. [DOI: 10.1038/s41380‐018‐0020‐x; PUBMED: 29463886]

Fedorenko 2016

Fedorenko E, Morgan A, Murray E, Cardinaux A, Mei C, Tager‐Flusberg H, et al. A highly penetrant form of childhood apraxia of speech due to deletion of 16p11.2. European Journal of Human Genetics 2016;24(2):302‐6. [DOI: 10.1038/ejhg.2015.149; PMC4717199; PUBMED: 26173965]

Gillon 2000

Gillon GT. The efficacy of phonological awareness intervention for children with spoken language impairment. Language, Speech and Hearing Services in Schools 2000;31(2):126‐41. [DOI: 10.1044/0161‐1461.3102.126; PUBMED: 27764385]

Goldman 2000

Goldman R, Fristoe M. Goldman‐Fristoe Test of Articulation‒2. 2nd Edition. Minneapolis (MN): Pearson Assessments, 2000.

Gozzard 2004

Gozzard H, Baker E, McCabe P. Single Word Test of Polysyllables. Unpublished manuscript2004.

GRADEpro GDT 2015 [Computer program]

McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed prior to 30 April 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.

Higgins 2011a

Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. [DOI: 10.1136/bmj.d5928; PMC3196245; PUBMED: 22008217]

Higgins 2011b

Higgins JPT, Deeks JJ, Altman DG, editor(s). Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Jacks 2006

Jacks A, Marquardt TP, Davis BL. Consonant and syllable structure patterns in childhood apraxia of speech: developmental change in three children. Journal of Communication Disorders2006; Vol. 39, issue 6:424‐41. [DOI: 10.1016/j.jcomdis.2005.12.005]

Lai 2001

Lai CS, Fisher SE, Hurst JA, Vargha‐Khadem F, Monaco AP. A forkhead‐domain gene is mutated in a severe speech and language disorder. Nature 2001;413(6855):519‐23. [DOI: 10.1038/35097076; PUBMED: 11586359]

Liégeois 2012

Liégeois FJ, Morgan AT. Neural bases of childhood speech disorders: lateralization and plasticity for speech functions during development. Neuroscience and Biobehavioral Reviews 2012;36(1):439‐58. [DOI: 10.1016/j.neubiorev.2011.07.011; PUBMED: 21827785]

Liégeois 2014

Liégeois F, Mayes A, Morgan A. Neural correlates of developmental speech and language disorders: evidence from neuroimaging. Current Developmental Disorders Reports 2014;1(3):215‐27. [DOI: 10.1007/s40474‐014‐0019‐1; PUBMED: PMC4104164]

Liégeois 2016

Liégeois FJ, Hildebrand MS, Bonthrone A, Turner SJ, Scheffer IE, Bahlo M, et al. Early neuroimaging markers of FOXP2 intragenic deletion. Scientific Reports 2016;6(35192):1‐9. [DOI: 10.1038/srep35192; PMC5062117; PUBMED: 27734906]

Maas 2008

Maas E, Robin DA, Austermann Hula SN, Freedman SE, Wulf G, Ballard KJ, et al. Principles of motor learning in treatment of motor speech disorders. American Journal of Speech‐language Pathology 2008;17(3):277‐98. [DOI: 10.1044/1058‐0360(2008/025); PUBMED: 18663111]

Maas 2014

Maas E, Gildersleeve‐Neumann CE, Jakielski KJ, Stoeckel R. Motor‐based intervention protocols in treatment of childhood apraxia of speech (CAS). Current Developmental Disorders Reports 2014;1(3):197‐206. [DOI: 10.1007/s40474‐014‐0016‐4; PMC4192721; PUBMED: 25313348]

McNeill 2009

McNeill BC, Gillon GT, Dodd B. Effectiveness of an integrated phonological awareness approach for children with childhood apraxia of speech (CAS). Child Language Teaching and Therapy 2009;25(3):341‐66. [DOI: 10.1177/0265659009339823]

Mei 2017

Mei C, Fedorenko E, Amor DJ, Boys A, Hoeflin C, Carew P, et al. Speech and language phenotype in 16p11.2 deletion. European Journal of Human Genetics2017 (in press).

Moher 2009

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097; PMC2707599; PUBMED: 19621072]

Morgan 2017

Morgan A, Fisher SE, Scheffer IE, Hildebrand M. FOXP2related speech and language disorders. 2016 Jun 23 [updated 2017 Feb 2]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. editor(s). GeneReviews®. Seattle (WA): University of Washington, 1993‐2018. [www.ncbi.nlm.nih.gov/books/NBK368474/?report=reader#_NBK368474_pubdet_]

Morgan 2018

Morgan AT, van Haaften L, van Hulst K, Edley C, Mei C, Yang Tan T, et al. Early speech development in Koolen de Vries Syndrome limited by oral praxis and hypotonia. European Journal of Human Genetics2018; Vol. 26, issue 1:75‐84. [DOI: 10.1038/s41431‐017‐0035‐9; PUBMED: 29225339]

Morley 1954

Morley ME, Court D, Miller H. Developmental dysarthria. British Medical Journal 1954;1(4852):8‐10. [PMC2093079]

Morley 1972

Morley ME. The Development and Disorders of Speech in Childhood. Baltimore (MD): Williams & Wilkins Co., 1972. [ISBN 0443008957]

Murray 2012

Murray E, McCabe P, Ballard KJ. A comparison of two treatments for childhood apraxia of speech: methods and treatment protocol for a parallel group randomised control trial. BMC Pediatrics 2012;12:112. [DOI: 10.1186/1471‐2431‐12‐112; ACTRN12612000744853; PMC3441276; PUBMED: 22863021]

Peter 2017

Peter B, Lancaster H, Vose C, Fares A, Schrauwen I, Huentelman M. Two unrelated children with overlapping 6q25.3 deletions, motor speech disorders, and language delays. American Journal of Medical Genetics. Part A 2017;173(10):2659‐69. [DOI: 10.1002/ajmg.a.38385; PUBMED: 28767196]

RCSLT 2011

Royal College of Speech and Language Therapists (RCSLT). Developmental verbal dyspraxia policy statement. www.rcslt.org/speech_and_language_therapy/rcslt_position_papers (accessed prior to 21 March 2018).

Review Manager 2014 [Computer program]

Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Schünemann 2017

Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Akl E, et al. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook.

Shriberg 2010

Shriberg LD, Fourakis M, Hall SD, Karlsson HB, Lohmeier HL, McSweeny JL, et al. Extensions to the Speech Disorders Classification System (SDCS). Clinical Linguistics & Phonetics 2010;24(10):795‐824. [DOI: 10.3109/02699206.2010.503006; PMC2941221; PUBMED: 20831378]

Shriberg 2011

Shriberg LD, Potter NL, Strand EA. Prevalence and phenotype of childhood apraxia of speech in youth with galactosemia. Journal of Speech, Language, and Hearing Research 2011;54(2):487‐519. [DOI: 10.1044/1092‐4388(2010/10‐0068); PMC3070858; PUBMED: 20966389]

Turner 2015

Turner SJ, Mayes AK, Verhoeven A, Mandelstam SA, Morgan AT, Scheffer IE. GRIN2A: an aptly named gene for speech dysfunction. Neurology 2015;84(6):586‐93. [DOI: 10.1212/WNL.0000000000001228; PMC4335991; PUBMED: 25596506]

Vargha‐Khadem 2005

Vargha‐Khadem F, Gadian DG, Copp A, Mishkin M. FOXP2 and the neuroanatomy of speech and language. Nature Reviews: Neuroscience 2005;6(2):131‐8. [DOI: 10.1038/nrn1605; PUBMED: 15685218]

Velleman 2011

Velleman SL, Mervis CB. Children with 7q11.23 Duplication Syndrome: speech, language, cognitive, and behavioral characteristics and their implications for intervention. Perspectives on Language Learning and Education 2011;18(3):108‐16. [DOI: 10.1044/lle18.3.108; PMC3383616; PUBMED: 22754604]

White 2010

White SM, Morgan A, Da Costa A, Lacombe D, Knight SJ, Houlston R, et al. The phenotype of Floating‐Harbor syndrome in 10 patients. American Journal of Medical Genetics. Part A 2010;152A(4):821‐9. [DOI: 10.1002/ajmg.a.33294; PUBMED: 20358590]

Williams 2004

Williams P, Stephens H, editor(s). The Nuffield Centre Dyspraxia Programme. 3rd Edition. London (UK): The Nuffield Centre Dyspraxia Programme Ltd., 2004. [www.ndp3.org]

Williams 2010

Williams P, Stephens H. The Nuffield Centre Dyspraxia Programme. In: Williams AL, McLeod S, McAuley RJ editor(s). Interventions for Speech Sound Disorders in Children. Baltimore (MD): Brookes Publishing Company, 2010:159‐77.

Yoss 1975

Yoss KA. Developmental apraxia of speech in children: familial patterns and behavioral characteristics. American Speech and Hearing Association North Central Regional Conference, 1975 May 9; Minneapolis (MN). 1975.

References to other published versions of this review

Morgan 2006

Morgan A, Vogel A. Intervention for developmental apraxia of speech. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD006278]

Morgan 2008

Morgan AT, Vogel AP. Intervention for childhood apraxia of speech. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD006278.pub2; PUBMED: 18646142]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Murray 2015

Methods

Parallel‐group randomised controlled trial

Participants

Sample size: 26 children

Dropouts/withdrawals: 1 child in the NDP‐3 group dropped out mid‐treatment yet was included in the analysis using intention‐to‐treat analysis

Sex: 18 males, 8 females

Mean age: 5 years and 6 months (SD = 25 months)

Inclusion criteria

  1. Clinical diagnosis of confirmed CAS, specified as having all 3 features of the ASHA 2007 consensus‐based position paper, and at least 4 out of 10 features from the 'Strand' checklist (Shriberg 2010)

  2. Aged between 4 and 12 years at time of treatment

  3. Standard score of ≧ 85 for receptive language of CELF‐IV or CELF‐P2

  4. Normal or adjusted‐to‐normal hearing and vision

  5. Child and at least 1 parent being native Australian‐English speakers

  6. No other diagnosed developmental or genetic disorders (e.g. dysarthria, autism or intellectual disability)

No information was collected on race, ethnicity or socioeconomic status

Interventions

Process
Participants were randomly assigned to 1 of the 2 treatments: ReST or NDP‐3. Concealed allocation was revealed after baseline assessment was completed. No significant differences between groups for any baseline variables (age, sex, primary or secondary outcome measures or CAS severity). Dose was controlled. Treatment was delivered for both ReST and NDP‐3 over 12 x 1‐hour sessions, scheduled 4 days/week for 3 weeks in school vacation time in January 2011 and January 2012, with a maximum of 10 participants per block. Treatments were provided as per intervention manuals and published protocol (Murray 2012). ReST sessions had an average of 100.4 production trials (SD = 0.9) and NDP‐3 had an average of 101.3 (SD = 1.2), with no significant difference in number of production trials between groups. Therapy was provided by student SLPs under the supervision of Murray and McCabe. Several days of training were provided for both treatments and in transcription and data collection until reaching inter‐rater reliability > 85%. Further detail on each treatment is provided below

  1. ReST: this treatment is based on principles of motor learning. There were 3 goal levels within the treatment: (1) 2‐syllable C1V1C2V2 (e.g. bagu or fabi), (2) 3‐syllable C1V1C2V2C3V3 (e.g. baguti or fabitu), (3) 3‐syllable pseudo words as final nouns within carrier phrases (e.g. "Can I have a baguti?"). Children were required to practise production of 20 pseudo words, with a goal of 80% accuracy of production in perceptually rated articulation, coarticulation and prosody over 2 consecutive sessions before stepping up to the next goal level. The child's initial goal level was selected dependent upon initial diagnostic testing prior to the pre‐treatment experimental probe. Consonants in the stimuli were individually selected for each child to ensure all target sounds were at least 10% stimulable and were maximally different fricative and plosive sounds (e.g. /b/, /f/, /t/, /g/), again based on pre‐treatment data. Stimuli were designed so that half had a strong‒weak pattern and the remainder a weak‒strong pattern, with the third syllable being either strong (using "ee" (/i/)) or weak (using "er", the Australian schwa). All pseudo words had a high phonotactic probability and were orthographically biased. Sessions consisted of pre‐practice and practice components. In pre‐practice, which lasted 10 to 15 minutes, the clinician aimed to elicit at least 5 correct productions of any of the 20 stimuli using imitation, phonetic placement cues, tapping of stress pattern, segmenting and blending and prosodic cues in addition to 'knowledge of performance' feedback after each production. In practice, which lasted around 50 minutes, the participant worked toward the goal of 80% accuracy with no cues given across 100 trials. Trials were delivered in 5 blocks of 1 trial of each of the 20 treated stimuli, presented in random order. 'Knowledge of results' feedback was provided 50% of the time on a decreasing scale (i.e. on 9 of the first 10 trials, down to only 1 of the final 10 trials). See Murray 2012 and Murray 2015 for further detail

  2. NDP‐3: the NDP‐3 intervention was conducted as described in the manual (Williams 2004) and subsequent publication (Williams 2010). Treatment goals targeted unknown segments as single sounds or syllable shapes using known sounds. Each goal was targeted during a game‐based activity, treated in a separate block of 18 minutes and was associated with 5 individualised stimuli. Children were required to achieve 90% accuracy for each target stimulus before moving on to different stimuli within the same goal. Verbal instructions, modelling and articulation, and visual‒tactile cues were provided as needed. 'Knowledge or results' and 'knowledge of performance' feedback was provided 100% (i.e. after every production attempt). If the production was correct, the child was then asked to repeat the response a further 3 times, again with immediate knowledge of results and knowledge of performance feedback by the clinician

Outcomes

Timing of outcome assessment
Outcome assessments were conducted prior to treatment and within 1 week, 1 month and 4 months post‐treatment. No therapy was reported between study onset and 1 month post‐treatment yet over half the cohort resumed community SLP services between 1 and 4 months post‐treatment (ReST = 9, NDP‐3 = 9)

Primary outcomes
The primary outcomes included:

  1. treatment gains;

  2. maintenance of treatment gains; and

  3. expected response generalisation to untreated real words and pseudo words using experimental probe items at the child's individualised generalisation level

Outcomes were measured based on a 292‐item experimental probe of treated and untreated stimuli. 162 items from NDP‐3 assessment and 80 pseudo words from ReST treatment, and an additional 50 untreated 1‐, 2‐ and 3‐syllable real word stimuli were used to test for generalisation of treatment effects in both groups. The probe assessed impairment level speech outcomes for simultaneous accuracy for articulation and prosody. For further detail on scoring, see Murray 2015.

Secondary outcomes
A number of secondary measures of generalization were made to further explore potential differences in the treatments' effects

  1. Imitated word accuracy in untreated connected speech of at least 3 words (as per NDP‐3 manual; Williams 2004, p 143)

  2. DEAP (Dodd 2006) inconsistency subtest

  3. Single Word Test of Polysyllables (Gozzard 2004) (only administered at pre‐treatment and 1‐month post‐treatment)

  4. GFTA‐2 (Goldman 2000) was administered at pre‐treatment and 1‐month post‐treatment to document changes in segmental accuracy using per cent phonemes correct (PPC), per cent vowels correct (PVC), per cent consonants correct (PCC) as well as per cent lexical stress (prosodic) matches for untreated single words in these clinically available assessments. For further detail on scoring, fidelity, reliability and recording, see Murray 2015

Comparisons
3 comparisons for each primary and secondary outcome measure were conducted

  1. Pre‐treatment compared with 1 week post‐treatment to assess acquisition of treatment and generalization effects

  2. 1 week versus 1 month post‐treatment to assess short‐term maintenance of these effects

  3. 1 week versus 4 month post‐treatment to test longer‐term maintenance with exception of the Single Word Test of Polysyllables (Gozzard 2004) and GFTA‐2 (Goldman 2000), which were only administered pre‐treatment and 1 month post‐treatment

Notes

Funding
Douglas and Lola Douglas Scholarship on Child and Adolescent Health; Speech Pathology Australia funded Nadia Verrall Memorial 2010 and Postgraduate Student Scholarship, James Kentley Memorial Scholarship, Postgraduate Research Support Schemes and Faculty of Health Sciences; University of Sydney International Development Program Fund; and Australian Research Council Future Fellowship

Conflicts of interest: none known

Study start date: January 2010

Study end date: July 2012

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Clarification was sought from the corresponding author by phone who confirmed that each envelope had a note within it specifying the treatment condition to which the child was allocated (Murray 2015). The authors could not see through the envelopes. Envelopes were placed in a container and an independent person (corresponding author's husband) not involved in the study selected an envelope that was then given a participant number (P1, P2, etc.) until all participants were allocated to an arm of the study. Allocation was not revealed until after the pre‐treatment evaluation

Allocation concealment (selection bias)

Low risk

Clarification was sought from corresponding author (Murray 2015), who confirmed via email that envelopes were sequentially numbered based on the random order in which they were selected from a container (i.e. randomised and not based on any identifying variable).

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

SLP could not be blinded to type of intervention

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Blinded, independent assessors

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No attrition

Selective reporting (reporting bias)

Low risk

All outcome measures reported in the original protocol, Murray 2012, were reported. A lexical stress measure was added in final outcome ratings but not mentioned in protocol but this was an addition and not a failure to report

Other bias

Unclear risk

  1. Maintenance findings. Some children resumed their usual therapy in the 4‐month period to maintenance assessment. Whilst the number of children resuming usual treatment was similar between both groups, this variable may have led to increased maintenance results across both treatments

  2. No control group without intervention (i.e. no wait‐list control group)

  3. Pre‐ and post‐treatment assessors

Qualified SLPs who had not seen the children previously conducted the 1 week, 1 month and 4 month post‐assessments. In some cases, final‐year undergraduate SLP students (4th‐year students) conducted post‐assessments. The same SLP or student SLP must not have seen/rated the children before. One researcher performed all of the pre‐assessments, including probes, before allocation was revealed

CAS: childhood apraxia of speech;CELF‐IV: Clinical Evaluation of Language Fundamentals ‐ Fourth Edition; CELF‐P2: Clinical Evaluation of Language Fundamentals ‐ Preschool 2; DEAP: Diagnostic Evaluation of Articulation and Phonology; GFTA‐2: Goldman‐Fristoe Test of Articulation 2;NDP‐3: Nuffield Dyspraxia Programme ‐ Third Edition; ReST: Rapid Syllable Transitions Treatment; SD: standard deviation; SLP: speech language pathologist

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Baas 2008

Not RCT or quasi‐RCT (case study)

Ballard 2010

Not RCT or quasi‐RCT

Beathard 2008

Not RCT or quasi‐RCT (case study)

Binger 2007

Not RCT or quasi‐RCT (case study series)

Binger 2008

Not RCT or quasi‐RCT (case study)

Binger 2011

Not RCT or quasi‐RCT (case study)

Bornman 2001

Not RCT or quasi‐RCT (case study)

Bose 2001

Not RCT or quasi‐RCT (case study series)

Carter 2004

Not RCT or quasi‐RCT (case study series)

Chappell 1973

No experimental treatment data included in study

Culp 1989

Not RCT or quasi‐RCT (single case [ABA] design)

Cumley 1999

Not RCT or quasi‐RCT (case series)

Dale 2013

Not RCT or quasi‐RCT (case series)

Daly 1972

Not RCT or quasi‐RCT (case study)

Dworkin 1988

Study examined adult participant with AAOS

Edeal 2011

Not RCT or quasi‐RCT

Forrest 2001

Study focuses on children with speech disorder, not specifically DAS. No experimental treatment data included in study

Groenen 1996

No experimental treatment data included in study

Hadar 1984

Study examined adult participant with AAOS

Hall 1989

Not RCT or quasi‐RCT (case study)

Hall 1990

Not RCT or quasi‐RCT (longitudinal case study)

Harris 1996

Not RCT or quasi‐RCT (case study)

Hayden 2006

Study uses a hypothetical treatment case only. No experimental treatment data

Head 1975

Study focuses on intervention for a group of participants with a range of speech disorders without dissociating between participants with subtypes of speech disorders. Does not report treatment efficacy specific to participants with DAS

Helfrich‐Miller 1994

Not RCT or quasi‐RCT (case study series)

Iuzzini 2010

Not RCT or quasi‐RCT (case study)

Jaroma 1984

Study does not specify whether child has diagnosis of DAS or only some features of dyspraxia

Kadis 2014

Not RCT or quasi‐RCT (case study series)

Katz 2006

Study examined adult participants with AAOS

King 2013

Not RCT or quasi‐RCT (case study series)

Kingston 1987

Study focused on articulation disorders, not specifically DAS

Klick 1985

No experimental treatment data included in study

Krauss 1982

Not RCT or quasi‐RCT (case study)

Lagasse 2012

Not RCT or quasi‐RCT (case study)

Lozano 1978

Study examined adult participant with AAOS

Lundeborg 2007

Not RCT or quasi‐RCT (case study)

Lüke 2016

Not RCT or quasi‐RCT (case study)

Maas 2012a

Not RCT or quasi‐RCT (case study)

Maas 2012b

Not RCT or quasi‐RCT (case study)

Martikainen 2011

Not RCT or quasi‐RCT

Martin 2016

Not RCT or quasi‐RCT (case study series)

McCabe 2014

Not RCT or quasi‐RCT (case study)

McNeill 2009a

Not RCT or quasi‐RCT (case series)

McNeill 2009b

Not RCT or quasi‐RCT (case study)

McNeill 2010

Not RCT or quasi‐RCT (case study series)

Morgan Barry 1995

Not RCT or quasi‐RCT (case study series)

Moriarty 2006

Not RCT or quasi‐RCT (case study)

Namasivayam 2013

Not RCT or quasi‐RCT (case study series)

Namasivayam 2015

Not RCT or quasi‐RCT (pre‐post group design)

Preston 2013

Not RCT or quasi‐RCT

Preston 2016

Not RCT or quasi‐RCT (case study)

Preston 2017

Not RCT or quasi‐RCT (case study)

Ray 2003

Study examined adult participant with AAOS

Richardson 2004

Study focus on motor dyspraxia or developmental coordination disorder not apraxia of speech

Rosenbek 1974

Not RCT or quasi‐RCT (case study)

Rosenthal 1994

Study combined a number of treatment methods and grouped individuals. Could not determine individual participant outcomes related to specific treatment methods

Skelton 2014

Not RCT or quasi‐RCT (case study)

Square 1994

No experimental treatment data included in study

Stokes 2010

Not RCT or quasi‐RCT (case study)

Strand 2000

Not RCT or quasi‐RCT (case study)

Strand 2006

Not RCT or quasi‐RCT (case series)

Thomas 2014

Not RCT or quasi‐RCT (case study)

Thomas 2016

Not RCT or quasi‐RCT (case study)

Tierney 2016

Not RCT or quasi‐RCT (case study)

Vashdi 2013

Not RCT or quasi‐RCT

Vashdi 2014

Not RCT or quasi‐RCT

Velleman 1994

Not RCT or quasi‐RCT (case series)

Yoss 1974

Not RCT or quasi‐RCT

Zaretsky 2010

Not RCT or quasi‐RCT (case study)

AAOS: acquired apraxia of speech.
ABA: applied behaviour analysis
DAS: developmental apraxia of speech.
RCT: randomised controlled trial.

Study flow diagram
Figuras y tablas -
Figure 1

Study flow diagram

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Nuffield Dyspraxia Programme ‐ Third Edition (NDP‐3) versus Rapid Syllable Transition Treatment (ReST) for Childhood Apraxia of Speech

Patient or population: children aged 4 to 12 years with CAS of unknown cause

Settings: University of Sydney Communication Disorders Treatment and Research Clinic

Intervention: NDP‐3

Comparison: ReST

Outcomes

Summary of MD findings

Absolute MD

Number of participants (studies)

Quality of the evidence
(GRADE)

Comments

Primary outcomes

Accuracy of production on treated items

Measured by: counting the number of real words produced correctly (/x)

Follow‐up: pre‐intervention to 1 month post‐intervention

NDP‐3 MD of 36.0 was greater than the ReST MD of 33.9

2.1

26 (1 trial)

⊕⊕⊕⊝
Moderatea

Accuracy of production on non‐treated items

Measured by: counting the number of real words produced correctly (/x)

Follow‐up: pre‐intervention to 1 month post‐intervention

ReST MD of 18.3 was minimally greater than the NDP‐3 MD of 18.2

0.1

26 (1 trial)

⊕⊕⊕⊝
Moderate a

Secondary outcomes

Speech production consistency

Measured by: calculating the number of inconsistent productions of 25 words produced 3 times using the DEAP inconsistency subtestb

Follow‐up: pre‐intervention to 1 month post‐intervention

NDP‐3 MD of 11.1 was greater than the ReST MD of 10.9

0.2

26 (1 trial)

⊕⊕⊕⊝
Moderate a

Accuracy of connected speech

Measured by: counting the number of correct imitations of 3 word phrases (/x)

Follow‐up: pre‐intervention to 1 month post‐intervention

NDP‐3 MD of 14.3 was greater than the ReST MD of 11.5

2.8

26 (1 trial)

⊕⊕⊕⊝
Moderate a

GRADE Working Group grades of evidence

High quality: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate quality: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
Low quality: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low quality: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

CAS: childhood apraxia of speech; DEAP: Diagnostic Evaluation of Articulation and Phonology; MD: mean difference; NDP‐3: Nuffield Dyspraxia Programme ‐ Third Edition;ReST: Rapid Syllable Transition Treatment (ReST) for Childhood Apraxia of Speech

aWe downgraded the quality of evidence by one level, to moderate, for imprecision, as there was only one study for comparison.
bNote, a decrease in inconsistency is a positive outcome.

Figuras y tablas -
Table 1. Excluded, low‐quality evidence from observational studies (case‐series, case control)

Study

Participants

Methodology/paper type

Intervention

Intervention approach

Intervention intensity and duration

Outcome measures

Treatment outcomes

Timing of outcome measures

Methodological considerations

Baas 2008

1 male aged 12.8 years with CAS and charge syndrome

Not quasi‐/RCT (Single case (AB) design)

Dynamic Temporal and Tactile Cueing

Motor

Phase I and II: sessions 4 × per week; Phase III: weekly therapy. Study over 25 months. Home practice not reported

Articulation accuracy on 2‐item scale for treated items; speech rate

Phase I (core vocabulary): change on 4/6 targets. Maintained at last probe.

Phase II (core vocabulary): reached 100% accuracy for 3/5 words. Reduction of stereotypies.

Phase III: decreased speech rate from 94 to 71 SPM

Baseline and during treatment. No longer‐term follow‐up data

Lack of experimental control, multiple baselines, control, longer‐term follow‐up or generalisation data. Clinical file data used. No replication across participants. Assessors, participants, therapists not blinded

Ballard 2010

3 siblings (2 males, 1 female) aged 7.8 and 10.10 years with CAS

Not quasi‐/RCT (Single subject multiple baseline design across behaviours and participants)

Rapid Syllable Transition Treatment (ReST)

Motor

60‐minute sessions (100‐120 trials per session), 4 × per week for 12 sessions. Home practice not reported

Reading aloud 10 treated and 10 non‐treated non‐word strings; real word generalisation data; perceptual analysis of prosodic pattern and acoustic analysis using pairwise variability index

3/3 had significant gains in treated items and generalisation to same level of treated complexity. 2/3 generalised to lower and higher complexity non‐word items. Minimal generalisation to real words

Baseline data taken at beginning of every 4th session and at 4 weeks post‐treatment

No long‐term follow‐up data. Limited participants for generalisation of outcomes. No blinding of assessors, participants or therapists. No stimulus generalisation measures

Beathard 2008

1 female aged 3 years with CAS

Not quasi‐/RCT (Case description)

Music therapy

Other (alternative interventions)

30‐minute sessions over 9 months. 24 sessions in total

Descriptive data only

Commenced non‐verbal. At end, had 11 phonemes in inventory

Pre‐treatment and post‐treatment. No follow‐up data

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No replicable outcome measures. No statistical analysis. No blinding of assessors, participants or therapists. No follow‐up or generalisation data. Unclear which aspect of treatment provided outcomes or affect of maturation, schooling, etc. No replication across participants. No long‐term follow‐up data

Binger 2007

2 males aged 4.2 and 4.4 years with CAS and language disorder

Not quasi‐/RCT (Single case multiple baseline across participants)

Aided AAC Modeling

Augmentative and alternative communication

15‐minute sessions, 1 to 3 × per week for 10 to 15 sessions

Frequency of use of multi‐symbol messages in play scenarios

Significantly more frequent use of multi‐symbol messages using aided AAC as well as different types of messages. Maintained and generalised gains. Increased participation

Baseline × 3, every 2nd treatment session, and at 2, 4 and 8 weeks post‐treatment

CAS diagnosis unclear and not replicable. Limited outcome measures. No blinding of assessors. No response generalisation data taken (only stimulus generalisation)

Binger 2008

1 female (Latino) aged 3.4 years with CAS and suspected velocardiofacial syndrome

Not quasi‐/RCT (Single case multiple baseline across participants)

Aided AAC Modeling

Augmentative and alternative communication

10‐minute sessions, 1 to 3 × per week for 10 to 15 sessions

Frequency of use of multi‐symbol messages in play scenarios

Significantly more frequent use of multi‐symbol messages using aided AAC. Parental response to training excellent. Maintained and generalised gains

Baseline × 3, every 2nd treatment session, and at 2, 4 and 8 weeks post‐treatment

CAS diagnosis unclear and not replicable. No blinding of assessors. No response generalisation data taken (only stimulus generalisation)

Binger 2011

1 female aged 6 years with CAS and language disorder

Not quasi‐/RCT (Single case multiple baseline across behaviours)

Aided AAC Modeling

Augmentative and alternative communication

15‐minute sessions, 1 to 3 × per week for 10 to 15 sessions

Frequency of use of grammatical morphemes

Significantly more frequent use of grammatical morphemes using aided AAC. 2nd intervention period needed for 2/3 targets. Maintained gains

Baseline × 3, every treatment session, and 2, 4 and 8 weeks post‐treatment

CAS diagnosis unclear and not replicable. No blinding of assessors. No response generalisation data taken (only stimulus generalisation)

Bornman 2001

1 male aged 6.6 years with CAS, hemiplegia and seizures

Not quasi‐/RCT (Single case (ABA) design)

Voice output devices (Macaw)

Augmentative and alternative communication

60‐minute sessions for 2 sessions (training). Home practice focus

Frequency of appropriate responses to questions in structured discourse

Mother provided greater frequency and type of questions. Frequency of appropriate responses increased

2 × baseline, 2 × practice period, 1 × post‐treatment, and 4 weeks post‐treatment

Lack of experimental control, multiple baselines or control data.
CAS diagnosis unclear and not replicable. No statistical analysis.
Limited outcome measures. No blinding of assessors. Unclear dosage of home practice. No generalisation data. No long‐term follow‐up data

Carter 2004

1 male and 1 female aged 12 and 8 years respectively diagnosed with CAS. Additional 8 children (7 males) aged 4 to 7 years with persistent articulation errors

Not quasi‐/RCT (Case series ‐ single group study)

Electropalatography (EPG) on /t, d, k, g, s, z/

Motor

30‐minute sessions, 1 × per week for 10 weeks

Per cent consonants correct (PCC) and Probe Scoring System (PSS) on probe of 43 words

Significant difference noted for PSS for whole group. PCC scores improved in percentage

Pre‐treatment (baseline first session) and post‐treatment

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No follow‐up or generalisation data. No blinding of assessors

Culp 1989

1 female aged 8 years with CAS and intellectual disability

Not quasi‐/RCT (Single case (ABA) design)

Partners in Augmentative Communication Training (PACT)

Augmentative and alternative communication

30 to 90‐minute sessions daily after 3 days of intensive training. Home practice focus

Ratio of parent vs participant messages; ratio of successful/intelligible messages from child

Participant had greater frequency of messages compared to parent, and slightly higher frequency of successful measures (high baseline accuracy). Increased participation

Pre‐treatment and 2 months post‐treatment

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.
No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants

Cumley 1999

2 females and 1 male aged 3.4, 8 and 12.9 years respectively, with CAS (2 with intellectual disability and 1 with submucous cleft)

Not quasi‐/RCT (3 case studies/reports)

Combined communication boards and voice output devices

Augmentative and alternative communication

3.4‐year‐old: 2 to 3 × per week for 12 weeks

8‐year‐old: daily for 6 months

12‐year‐old: not reported

3.4‐year‐old: MLU.

8‐year‐old: assessment of phonological processes; communication repairs.

12‐year‐old: description of functional communication

3.4‐year old: minimal speech improvement, MLU increased to WNL

8‐year old: no change in speech, parent report of greater communication repairs, and less frustration

12‐year old: supplemented natural speech to initiate, maintain and repair communication

Pre‐assessment and treatment descriptions

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.
No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants

Dale 2013

3 males and 1 female aged 3.6 to 6 years diagnosed with CAS

Not quasi‐/RCT (Single subject (ABB or ABC) design)

Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT) ‐ full programme (FP) for 8 weeks versus PROMPT without tactile‐kinaesthetic‐proprioceptive cueing for 4 weeks and FP for 4 weeks

Motor

50‐minute session, 2 × per week for 8 weeks

Trained words on probe, untrained words. Pre‐post testing on the DEAP, TOCS+, VMPAC focal motor and sequencing subtests and Vineland socialization scales

2/4 improved on DEAP. 4/4 improved on TOCS+, VMPAC subtests and Vineland. All 4 showed greater improvement on easier targets and majority maintained to 3 months post‐treatment. Generalisation to untrained items noted

Probe words: baseline × 3, treatment × 4, post‐treatment, and 3 months post‐treatment

Lack of experimental control as control data changed and interpreted as generalisation but no other control used (e.g. multiple baselines). CAS diagnosis concerning prosody unclear. Blinded assessors for only some outcomes. No withdrawal period between treatment phases and participant differences made comparison between conditions difficult. All measures not taken at consistent times

Edeal 2011

2 males aged 6.2 and 3.4 years with CAS (1 case with repaired cleft lip and palate and language disorder)

Not quasi‐/RCT (Single case (AB) design)

Integral Stimulation (Dynamic Temporal and Tactile Cueing)

Motor

Varied across participants. 40‐minute sessions (15 minutes each condition plus probes). 1 case: 3 × per week for 11 weeks.
1 case: 2 × per week for 5 weeks

Probe data on targeted phonemes (articulation) in words for each participant. 1 phoneme targeted with high production frequency = 100 trials and another with moderate production frequency = 60 trials. Articulation and language sample taken at 2 weeks post‐treatment

Large effect sizes for high production frequency and moderate for moderate production frequency. Improvement in PCC and phoneme inventory post‐treatment. Some generalisation

Baseline × 3, each treatment session, and 1 probe post‐treatment

Lack of experimental control, multiple baselines or control data. No long‐term follow‐up data. No blinding of assessors. Accuracy based on if target phoneme was correct (including cognate pair substitution) not if whole word was correct

Hall 1989

1 female aged 9 years with mild CAS (followed until 12 years)

Not quasi‐/RCT (Case study/report)

Articulation therapy, motor‐programming remedial model

Motor

5 school semesters

Templin‐Darley Tests of Articulation

Remediation of all 31 items for /r/, /ɝ/ and /ɚ/

Test completed each semester

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.
No blinding of assessors. No follow‐up data or generalisation data. No replication across participants. No stimulus generalisation measures

Harris 1996

1 male aged 5 years with CAS and language disorder

Not quasi‐/RCT (Multiple baseline across discourse contexts)

Computer‐based AAC

Augmentative and alternative communication

4‐minute sessions, 2 × per week for 22 sessions over 4 months

Frequency of noun/verb phrases in reciprocal book reading and structured discourse

Improvement in both contexts but more so in book reading than discourse. Some generalisation

Baseline, treatment, and withdrawal probes

CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures. No follow‐up data. No blinding of assessors. No replication across participants

Helfrich‐Miller 1994

3 children (2 males, 1 female) aged 2.9 to 8 years with CAS

Not quasi‐/RCT (Case study series)

Melodic Intonation therapy (MIT)

Linguistic and motor

Varied. 37 to 71 sessions

Varied. Description of skills, consonant inventories, sequencing error rates and intelligibility compared to typical development

Child 1: all consonants in inventory

Child 2: spoke in complex sentences, poor intelligibility, and articulation errors present.

Child 3: sequencing error rate dropped from 75% to 22%. 13/18 consonant sounds improved

Pre‐ and post‐treatment

No experimental control. Lack of information on diagnosis of CAS. Primarily descriptive measures ‒ not reliable or tested using statistics. No control, maintenance or generalisation data

Iuzzini 2010

4 children (2 males, 2 females) aged 3.7 to 6.10 years with CAS

Not quasi‐/RCT (Single case design)

Stimulability (STP) and modified Core Vocabulary (mCVT) used concurrently

Linguistic and motor

55‐minute sessions (10 minutes STP, 45 minutes mCVT), 2 × per week for 20 sessions. No home practice

Per cent phonemes correct, phonetic inventory and inconsistency

PCC increased on average 20% after combined therapy (range 9% to 32%). Inventory gained 5 phones on average (range 1 to 10). 3/4 had greater consistency on CSIP and ISP after therapy; 1 had greater inconsistency

Pre‐ and post‐ treatment

Poor experimental control as stable baseline not established, lack of control data. CAS diagnosis unclear and not replicable. No statistical analysis. No blinding of assessors. No immediate post‐treatment data or generalisation data

Jaroma 1984

1 male aged 5.5 years with "some dyspraxic features" (CAS diagnosis not explicit)

Not quasi‐/RCT (Case study)

Sensory integrative therapy and speech therapy

Motor

Daily sessions for 2 months

(SP only) Illinois Test of Psycholinguistic Abilities

Test not completed post‐treatment. Observation of greater self‐monitoring and correction of speech

Pre‐treatment only

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures and no post‐treatment data.
No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants.
Lack of information on speech therapy provided

Kadis 2014

14 children (9 males, 5 females) aged 3 to 6 years with diagnosed CAS (compared to 14 age‐matched controls)

Not quasi‐/RCT (Case series pre‐post design)

Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT)

Motor

2 × per week for 8 weeks (16 sessions in total)

GFTA2, HCAPP,

VMPAC, MRI

Significant gains as a group for all speech measures

1‐week pre‐treatment (baseline), 1‐week post‐treatment

CAS diagnosis unclear and not replicable. Age‐matched control group older than CAS group. Limited information on PROMPT targets selected for replication. No blinding of assessors. No stimulus generalisation measures

King 2013

3 males aged 4.1, 5.8 and 8.6 years diagnosed with CAS. 1 of the 3 diagnosed with Opitz FG syndrome and another with PDD‐NOS

Not quasi‐/RCT (Single subject multiple baseline across participants design)

Integrated Multimodal Intervention (structured book reading, drill and play activities with AAC devices present and speech encouraged)

Augmentative and alternative communication

1‐hour sessions, 2 × per week for 3 to 6 weeks

Category (e.g. vocalisation, AAC or both), type of word and accuracy targets.

Case 1: final consonants.

Case 2: initial /s/ clusters then /f/.

Case 3: initial /s/ clusters

Increases in vocalisations/spoken speech noted for 3/3. Speech accuracy improved on targets for 1/3 cases but all showed some generalisation to more accurate everyday speech

Baseline probes, probes every 2nd treatment session, 1‐month post‐treatment

Poor experimental control for case 1 and some change on control data noted. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.
No blinding of assessors. No generalisation data. No long‐term treatment data

Klick 1985

1 female aged 5.6 years with CAS

Not quasi‐/RCT (Case description)

Adapted Cueing Technique

Motor

30 minutes of therapy per day for 6 months

Number of single words/utterances

From 2 to 4 words to 12 words and several carrier phrases. After 6 months began to produce novel sentences

Description of progress during treatment

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.
No blinding of assessors. No follow‐up or generalisation data. No replication across participants

Krauss 1982

2 males aged 5 and 6 years diagnosed with CAS

Not quasi‐/RCT (Single case (ABAA) design)

Concurrent Melodic Intonation Therapy (MIT) and traditional therapy (20% and 80% of sessions respectively)

Linguistic and motor

2 × per week over 2‐month period

Pre‐ and post‐treatment gains on word‐morpheme usage, auditory comprehension, naming, describing function, sentence completion, imitation of word phrases and articulation. Tested using language sampling and Porch Index of Communicative Ability in Children

Significant gains were found in phrase length (MLU), picture naming, and verbal imitation tasks. Little change in articulation

Pre‐treatment, post‐traditional therapy, and post‐MIT therapy

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable.
No blinding of assessors. No immediate post‐treatment data or generalisation data. No long‐term follow‐up. There were no reliability data reported for language sample analysis, a subjective measure

Lagasse 2012

2 males aged 5 and 6 years with suspected CAS

Not quasi‐/RCT (Single case (AB) design)

Melodic Intonation Therapy (MIT) compared to 'traditional speech‐language therapy'

Linguistic and motor

Ongoing 1 × per week speech therapy (traditional articulation sessions) and 40‐minute MIT music sessions over 4 weeks (both treatments concurrent)

GFTA2; KLPA2 and speech production on stimulable sounds in 1‐ or 2‐syllable words

Case 1 made greater gains in MIT sessions (but only 2% gain). Case 2 made greater gains on traditional articulation therapy (15% gain)

Pre‐ and post‐ treatment

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.
No blinding of assessors. No follow‐up or generalisation data

Lüke 2016

1 German‐speaking male aged 2.7 years with severe CAS

Single case design (A‐B design with 3 follow‐up assessments post‐treatment with some treatment sessions between assessments)

Speech Generating Devices ‒ fixed display (Gotalk 20+) and dynamic display (DynaVox V)

Augmentative and alternative communication

45‐minute sessions × 50 treatment sessions. Treatment sessions 2 to 28 days apart

Means of communication (oral versus SGD), intelligibility of speech productions, consistency of speech productions, lexical development, and grammatical development

Significantly more communication initially with SGD than speech; significant increase in speech intelligibility; consistency (however reduced data in baseline period); amount of words used; and increased MLU and inflections after 8 to 9 sessions

Baseline × 3, every 2nd treatment session, and 2, 4 and 8 weeks post‐treatment

Lack of baseline data for consistency. CAS diagnosis unclear and not replicable. No blinding of assessors. No clear withdrawal phase after treatment with SGDs for control and no generalisation data

Lundeborg 2007

1 female aged 5.1 years with CAS

Not quasi‐/RCT (Single case cross‐over design)

Intra‐oral stimulation and electropalatography

Motor

25‐minute sessions (5 minutes intra‐oral stim, 20 minutes EPG); daily at home, total of 195 sessions in 12 months

Per cent consonants correct, per cent phonemes correct, per cent words correct, intelligibility, visual deviancy

Significant treatment outcomes on all measures

Pre‐testing, A1 (baseline), B (intervention: oral stimulation therapy), A2 (withdrawal for 3 months), B (intervention: EPG), and A3 (follow‐up)

Cross‐over design, no control group or data taken to control for maturation. No replication across participants. No long‐term follow‐up or generalisation data taken

Maas 2012a

4 children (2 males, 2 females) aged 5.4 to 8.4 years with CAS (2 also with dysarthria and a third with language disorder); 3 also in Maas 2012b, as below

Not quasi‐/RCT (Single case alternating treatments design with multiple baselines across behaviours over
2 phases)

Dynamic Temporal and Tactile Cueing (high versus moderate feedback frequency in cross‐over design)

Motor

50‐minute sessions 3 × per week for 3 participants but 1 had 60‐minute sessions 2 × per week

Per cent accuracy on 2‐point scale of segmental and suprasegmental aspects of target words and phrases with 2 words

2 responded better to low frequency feedback, 1 to high frequency feedback, and 1 to no condition. No generalisation effects

Weekly probes: 3 to 4 × baseline, 4 × treatment. Phase 1: 4 to 5 × withdrawal, 4 × treatment. Phase 2: 2 × withdrawal and 1 month post‐treatment

Small sample size with heterogeneity. Cross‐over conditions made comparison difficult regarding targets chosen. No control group. Effect sizes used not interpretable or comparable to others. Different doses across all participants. Treatment fidelity < 80%. No stimulus generalisation measures

Maas 2012b

4 children (2 males and 2 females) aged 5.0 to 7.9 years with CAS. 2 cases had additional dysarthria diagnoses.

1 other case had multiple co‐occurring disorders

Not quasi‐/RCT (Single case alternating treatments design with multiple baselines across behaviours over
2 phases)

Dynamic Temporal and Tactile Cueing (random versus blocked practice compared in cross‐over design)

Motor

2 × 4 week blocks of therapy

Per cent accuracy on 2‐point scale of segmental and suprasegmental aspects of entire target words and phrases with 2 words

3/4 responded to both conditions. 2 responded relatively better to blocked practice, 1 to random practice, and 1 to no condition. 2/4 demonstrated generalization

Weekly probes: 3 to 4 × baseline, 4 × treatment. Phase 1: 4 to 5 × withdrawal, 4 × treatment. Phase 2: 2 × withdrawal and 1 month post‐treatment

Small sample size with heterogeneity. Cross‐over conditions made comparison difficult regarding targets chosen. No control group. Effect sizes used not interpretable or comparable to others. Treatment fidelity < 80%. No stimulus generalisation measures

Martikainen 2011

1 female aged 4.7 years with CAS

Not quasi‐/RCT (Multiple baseline across behaviours ‐ cross‐over treatment design)

Combined Melodic Intonation Therapy (MIT) and Touch Cue Method (TCM)

Motor and linguistic

3 sessions for 6 weeks for 18 sessions for MIT. 6 weeks no therapy. 3 sessions for 6 weeks for 18 sessions for TCM

Articulation accuracy: PVC, PCC. Also, overall word accuracy scores: PMLU, PWP, PWC.

All calculated from responses to 46 picture cards

1/5 measures significant post‐MIT (per cent vowels correct). Per cent consonants correct also reduced.

3/5 significant post‐TCM (PVC, PCC, PMLU).

PVC, PCC and PMLU maintained.

Greater changes for both therapies after withdrawal. PCC and PMLU only significant after MIT withdrawn

Beginning and end of 6‐week baseline, beginning and end of both treatment phases, 12 weeks after TCM withdrawn

Lack of experimental control of other factors. Cross‐over design makes comparison of both treatments difficult as many changes only noted after withdrawal of MIT (accumulation effects). Limited outcome data. Lack of generalisation data No blinded assessors. No replication across participants

Martin 2016

12 children (sex unknown) aged 3 to 10 years with CAS (11 with co‐occurring conditions)

Case series (pre and post design)

DuBard Association Method®. It is a multimodal, phonetic therapy which works from accurate sounds in isolation

Motor

Daily in small groups in a school programme for an 11‐month period

Articulation, mean length of utterance (MLU), and intelligibility on Arizona Articulation Proficiency
Scale‐Third Revision (AAPS‐3) and perceptions of resilience judged by parents and SLPs

Significant changes in articulation, intelligibility and MLU, and some resilience measures over 2‐year period

Pre‐ and post‐ treatment

Lack of experimental control regarding maturation effects (despite using the Intervention Efficiency Index and Proportional Change Index) and lack of control of covariate, including other potential intervention over the same period. No control group. No follow‐up or generalisation data

McCabe 2014

4 males aged 5.5 to 8.6 years with CAS. 2 children had additional auditory processing impairments

Not quasi‐/RCT (Single case (AB) design with 1 month follow‐up)

Rapid Syllable Transition Treatment (ReST)

Motor

60‐minute session, 4 × per week for 3 weeks (12 sessions in total). Minimum of 1200 trials per session

Articulation, prosodic and simultaneous articulation and prosodic accuracy on trained and untrained probe pseudo words; PCC, PVC and per cent lexical stress matches from connected speech; PPVT‐4 as control data

All 4 participants increased perceptual accuracy. 1/4 participants showed change in untreated items. All participants showed change in prosody (average prosody gain 58%, 3/4 in PVC and 2/4 in PCC; average gain 79%). Control data (receptive vocabulary on PPVT‐IV) changed minimally

Baseline × 2, probes in treatment × 2, 1 month follow‐up

There was no immediate post‐treatment data taken to determine treatment effects, the follow‐up data was 1 month post‐treatment and included a withdrawal phase. There was no statistical analysis of connected speech data. 1 participant reached ceiling. No blinding of assessors. No stimulus generalisation measures

McNeill 2009a

12 children (9 males, 3 females) aged 4.2 to 7.6 years with CAS

Not quasi‐/RCT (Case series design)

Integrated Phonological Awareness Intervention

Linguistic

45‐minute session; 2 × per week for 6 weeks in 2 blocks with 6‐week withdrawal between blocks. Total of 245 sessions

Trained speech accuracy and phonological awareness accuracy on a probe. Generalisation‐ BTOPP and first trial of DEAP inconsistency subtest for PVC, PVC and inconsistency score. PIPA for 4‐year‐olds. TOPA for 5 to 7‐year‐olds. Burt Word Reading Test for non‐word reading and informal non‐word reading probe (Gillon 2000). Per cent grapheme correct score in spelling 10 words from DEAP inconsistency subtest

Speech: 9/12 children improved on trained items. Phonological awareness: 8/12 children improved in 1 or both intervention blocks. Generalisation for 8/12 on all measures except Burt Word Reading Test

Pre‐ and post‐treatment

Lack of experimental control, control group or control data. CAS diagnosis unclear regarding prosody. Limited information provided on each participant. Limited treatment phase data. No maintenance data. No blinding of assessors

McNeill 2009b

2 male identical twins aged 4.5 years with CAS (deletion at 10q21.2‐22.1)

Not quasi‐/RCT (Single case design)

Integrated Phonological Awareness intervention

Linguistic

45‐minute session; 2 × per week for 6 weeks in 2 blocks with 6‐week withdrawal between blocks. Total of 245 sessions

PPC, PVC on BTOPP, and DEAP inconsistency percentage. PIPA, PhonRep, Burt Word Reading, Non‐word Reading, Neale accuracy and comprehension

PCC and PVC improved at post‐treatment and follow‐up. Reduced inconsistency. Sound‐letter knowledge increased from 0 to 7 at post‐treatment. Reading WNL and spelling demonstrated use of strategies at final follow‐up

Pre‐ and post‐ treatment, and 6‐month follow‐up

Lack of experimental control, control group or control data. CAS diagnosis unclear regarding prosody. Limited information provided on each participant. Limited treatment phase data. No maintenance data. No blinding of assessors. No stimulus generalisation measures

McNeill 2010

12 children (9 males, 3 females) aged 4.2 to 7.6 years diagnosed with CAS

Not quasi‐/RCT (12‐month follow‐up to 2009 case series)

Integrated Phonological Awareness intervention

Linguistic

As per McNeill 2009a

BBTOP and 1st trial of DEAP yielding PPC. PIPA for 4‐year‐olds & TOPA for 5 to 7‐year‐olds. Decoding measures (Burt Word Reading Test and Non‐word Reading Task) and spelling measures (probe of 10 words from the DEAP inconsistency subtest) were completed for participants at least 6 years of age at the beginning of the study. The NARA was administered for participants aged 5 years, 6 months and up

Significant difference for CAS group from pre‐ to post‐treatment on letter knowledge, non‐word reading probe, spelling, PCC, TOPA and Burt Non‐Word Reading. 3/7 improved on NARA to age‐appropriate level

1‐year follow‐up to McNeill 2009a

7/12 of original participants followed up. Whole group data ‒ case series. No control group or control data for experimental control or maturation effects

Moriarty 2006

3 children (2 males, 1 female) aged 6.3, 6.10 and 7.3 years with CAS

Not quasi‐/RCT (Single case multiple baseline design across behaviours)

Integrated Phonological Awareness Intervention

Linguistic

45‐minute sessions 3 × per week for 3 weeks

PPC on probe, phoneme segmentation probe, phoneme manipulation probes, initial sound identification probes, letter‒sound knowledge subtest from the PIPA, non‐word reading tasks

2/3 significantly increased PPC, 2/3 significantly improved phonological awareness skills on probes, letter‒sound knowledge, and non‐word reading. Limited transfer to untreated words

Baseline and post‐treatment (3 probes each)

Lack of control group and control data. CAS diagnosis unclear regarding prosody. Lack of multiple baseline data throughout treatment. No long‐term follow‐up. No blinding of assessors

Namasivayam 2013

12 children (9 males, 3 females) aged 3 to 6 years with speech sound disorders

Not quasi‐/RCT (Case series pre‐post design)

Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT)

Motor

45‐minute session 2 × per week for 8 weeks

GFTA2, HCAPP, VMPAC focal motor and sequencing subtests, Children's Speech Intelligibility Measure

Significant gains as a group for all speech measures

Baseline 1 week prior to treatment, and 1 week post‐treatment

Lack of experimental control, control group, multiple baseline or control data. No blinding of assessors. No blinding of assessors. No long‐term follow‐up

Namasivayam 2015

37 children (28 males, 9 females) aged 2.6 to 4.5 years with CAS

Not quasi‐/RCT (pre‐postgroup design)

Motor Speech Treatment Protocol (MSTP)

Motor

Intense treatment group: 45‐minute session, 2 × per week × 10 weeks = 20 sessions. Less intense group: 45‐minute session, 1 × per week × 10 weeks = 10 sessions

GFTA‐2 sounds in words subtest; speech intelligibility using Children's Speech Intelligibility Measure (CSIM) at word level, and Beginner's Intelligibility Test (BIT) at sentence level. Functional Outcomes for Children Under Six (FOCUS) scale

Intense group had greater changes in articulation and functional communication compared to the less intense group with large effect sizes. Mixed results were found for intelligibility: at word‐level (CSIM), both the less intense and 1/2 intense groups made a significant and large change. At sentence level, 1/2 intense groups made a significant change

Pre‐ and post‐ treatment

No control group or control data. Participants were not directly randomised; however, no between‐group differences were found at baseline. There were missing data (dealt with using intention‐to‐treat analysis). No information on session trials was obtained, which is important for intensity calculations

Preston 2013

6 males aged 9 to 15 years with CAS. 1 child had additional ADHD and another child had additional dysarthria

Not quasi‐/RCT (Single case multiple baseline across behaviours across participants)

Ultrasound biofeedback (targeting articulation on clusters and CV or VC sequences of inaccurate phones)

Motor (instrumentally based)

60 minute sessions, 2 × per week × 18 sessions (at least 150 trials per session)

Probe of whole‐word accuracy of treated and untreated items

U002 and U007 had significant gains on 2/4 treated combinations, U005 for 3/4, and U008, U009 and U012 had significant gains on all treated combinations. All exhibited some generalisation (target‐dependant). U005, U007, U008, U009, U012 demonstrated maintenance above pre‐treatment levels

Probes at baseline × 3, every treatment session, post‐treatment, and 2 months post‐treatment

No control group or comparison treatment. No blinding of assessors. Untreated items were not clearly selected as control or generalisation data with some showing change and others not

Preston 2016

3 male children aged 11 to 13 years diagnosed with CAS and poor expressive language and phonological processing. 1 participant had additional flaccid dysarthria, ADHD, language and learning difficulties

Not quasi‐/RCT (Single case multiple baseline across behaviours (syllable positions))

Ultrasound biofeedback (using structured chaining and principles of motor learning)

Motor (instrumentally based)

1 hour sessions × 14 sessions. Sessions 1 to 7 addressed target 1 and sessions 8 to 14 addressed target 2 with randomly assigned prosody or no prosody conditions

Treatment acquisition data, generalisation probe of untreated words, maintenance to 2 months post‐treatment

2/3 participants acquired accurate articulation. 0/3 demonstrated generalisation or maintenance

3 × baseline probes, midway therapy probe, post‐therapy probe (within 1 week after treatment), and 2‐month follow‐up

No control group. Greater within‐treatment probes and post‐treatment probes would have allowed for greater statistical analysis. No control data. No blinding of assessors. No stimulus generalisation measures

Preston 2017

3 males aged 11 to 14 years with CAS

Not quasi/RCT

(Single case (ABA) design)

Ultrasound biofeedback (using structured chaining and principles of motor learning.)

Motor (Instrumentally based)

2 × 1‐hour articulation treatment a day for 2 weeks. 16 hours of therapy in total. Over 100 trials per session

Treatment acquisition of /ɹ/, /s/ or /ʧ/. Generalisation to untrained items using a probe and sentence imitation task, and maintenance 1 to 3 weeks post‐treatment (audio‐samples submitted)

Case 1 had acquisition, generalisation, and maintenance of targets. Case 2 had some acquisition in the 2nd week of therapy and no generalisation and maintenance. Case 3 showed acquisition, limited generalisation to words and not phrases, and no maintenance

Probe conducted 1 × before treatment, at the end of the first week, and at the end of the second week (post‐treatment)

Lack of experimental control, multiple baselines or control data. No blinding of assessors. No long‐term follow‐up data. No stimulus generalisation measures

Ray 2003

1 adult with CAS and class III malocclusion. Another 5 adults aged 18 to 23 years with persistent articulation disorders

Not quasi‐/RCT (Case series)

Orofacial myofunctional therapy

Motor (Instrumentally based)

45‐minute session, 1 × per week for 6 weeks

Dworkin‐Culatta Oral Mechanism Examination for oral postures and intelligibility in single words, sentences, and spontaneous speech

All improved lips and tongue postures. 5/6 participants increased intelligibility. No improvement in intelligibility for person with DVD

Pre‐ and post‐treatment

Lack of experimental control, multiple baselines or control data. No treatment data or follow‐up reported. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.
No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants

Rosenbek 1974

1 female aged 9 years with CAS

Not quasi‐/RCT (Case study)

Intensive, systematic drill motor therapy

Motor

22 sessions over 3 months

20‐item probe of /r/ (target), ineligibility in spontaneous speech

/r/ improved from 0 to 20 correct in probe. Intelligibility judged by unfamilar listeners improved

Treatment sessions

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No follow‐up data. Only ancedotal generalisation data. No statistical analysis. No reliability of judgments reported. No replication across participants

Rosenthal 1994

4 children (3 males, 1 female) aged 10‐14 years diagnosed with CAS

Not quasi‐/RCT (Single subject (ABAB) design)

Rate Control Therapy

Linguistic and motor

20‐minute session per reading passage. No further information available

Articulation accuracy (words read correctly)

Improved to 85% accuracy at 50% habitual rate and maintained in therapy as rate was slowly increased. Limited generalisation to conversation ‐ therapy implemented

Reading rate in 5‐minute intervals

Lack of control and follow‐up data. CAS diagnosis unclear and not replicable. No statistical analysis. No blinding of assessors. No stimulus generalisation measures. No report of data reliability

Skelton 2014

3 children (2 males, 1 female) aged 4 to 6 years diagnosed with CAS

Not quasi‐/RCT (Single case multiple baseline design across participants)

Concurrent treatment (using randomised variable practice)

Motor

Therapy until target sounds reached 80% accuracy. P1 had 26, P2 had 12 and P3 had 28 sessions. 2 × per week, 30 minutes per session and on average 100 to 115 trials per session

Per cent correct productions on /s, z, f, v/ trained targets during baseline and treatment; generalisation probes to untrained words and 3‐word phrases

All children reached 80% accuracy on target sounds. Moderate to large generalisation effects at word and 3‐word phrases levels (70% to 100% accuracy)

3 × baseline probes, probes every 5 therapy sessions

No post‐treatment or follow‐up/maintenance data. No blinded assessors. No stimulus generalisation data. P3 continued regular school therapy during the study so could be a confounding factor. No stimulus generalisation measures

Stokes 2010

1 male aged 7 years with residual CAS

Not quasi‐/RCT (Single case (ABA) design)

Articulation with facilitative vowel contexts

Linguistic

45‐ to 55‐minute session, 3 × per week for 3 weeks. 60+ trials per session. Home practice provided

Accuracy on 'sh' sound in word initial probe, 'tr' as control

Significant improvement in 'sh' articulation accuracy in trained and untrained words. No change in control words with 'tr' initial

Pre‐treatment, mid‐therapy × 2 (after sessions 3 and 6), post‐treatment, and maintenance (2 weeks post‐treatment)

Participant did not meet current CAS criteria. Lack of generalisation data beyond 'sh' sound. No blinded assessors. No replication across participants. No long‐term follow‐up data. No reliability of data reported

Strand 2000

1 female aged 5 years with "severe motor planning deficits but no dysarthria" (CAS)

Not quasi‐/RCT (Single case multiple baseline design)

Integral stimulation

Motor

30‐ to 50‐minute session, 3 to 5 × per week (1 to 2 × per day) for 10 to 16 sessions. No home practice

Articulation accuracy ratings on a 2‐point scale

Improvement from 0.25 to 0.80 on 2‐point scale. 4/5 treatment stimuli achieved rating of 2/2 by end of therapy

Treated stimuli at start of each session, control stimuli twice a week

No statistical analysis. Limited outcome measures.
No blinding of assessors. No follow‐up data or generalisation data. No replication across participants

Strand 2006

4 males aged 5.5 to 6.1 years with CAS (2 with dysarthria and 1 with mild intellectual disability)

Not quasi‐/RCT (Single case multiple baseline across participants)

Dynamic Temporal and Tactile Cueing

Motor

30‐minute sessions, 2 × per day for 5 days a week for 38 to 50 sessions

Articulation accuracy on a 3‐point scale

Treatment gains for 3/4 participants maintained by 2/4

Baseline × 4 (or more, staggered baseline), 20+ treatment probes

No follow‐up or generalisation data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures

Thomas 2014

4 children (2 males, 2 females) aged 4.8 to 8 years with CAS

Not quasi‐/RCT (Single case multiple baseline across participants and behaviours)

Rapid Syllable Transition Treatment (ReST)

Motor

50 minute sessions 2 × per week for 6 weeks. 100 trials per session

Accuracy on imitated (a) treated words, (b) untreated pseudo words, (c) untreated real words and control words

Significant improvement on treated words and untreated real words. Significant improvement for 2/4 participants on untreated pseudo words. No change in control items

Baseline × 3 to 6, treatment × 3, and 1 day, 1 month and 4 months post‐treatment

Use of GFTA2 for control items. No stimulus generalisation data

Thomas 2016

5 children (4 males, 1 female) aged 5 to 11 years with CAS (3 with mild or moderate receptive language disorder)

Not quasi‐/RCT
(Single case multiple baseline across participants)

Rapid Syllable Transition Treatment (ReST)

Motor (instrumentally based ‐ telehealth)

60‐minute session, 4 times a week for 3 weeks (12 sessions in total). Minimum of 1200 trials per session

Accuracy on treated pseud‐word items, generalisation to untreated non‐words and real words, and control items (articulation of rhotics) on a probe; client/family satisfaction with telehealth treatment

5/5 participants demonstrated significant change in treated items. 4/5 maintained gains to 4 months post‐treatment. 4/5 had significant generalisation to untrained non‐words and real words, and 1/5 demonstrated change in control data (articulation errors of rhotics or /s/). Families very satisfied and motivated by telehealth treatment

At least 3 baseline probes, 3 therapy probes (sessions 5, 9 and 1 day post‐treatment). Follow‐up at 1 week, 4 weeks & 4 months post‐treatment

Missing data for some participants at certain time points in Table 3. Problems with change in control data. Some internet issues (dropouts, port sound quality, etc.) were observed in 61% of sessions; however, significant outcomes were found. No stimulus generalisation data

Tierney 2016

1 male aged 3 years with CAS and fine motor delay

Not quasi‐/RCT

(Single case design; descriptive)

Multimodal therapy: Signed Exact English sign language, Sarah Rosenfeld Johnson's oro‐motor programme and Kaufman Speech Praxis Program

Augmentative and alternative communication

Clinic‐based sessions 45 minutes 1 to 2 × per week and home‐based sessions for 60 minutes 1 × per week

Language assessment; observations and Kaufman Speech Praxis Test; Verbal Motor
Production Assessment for Children (VMPAC)

Receptive and expressive language consistently in average range but receptive relatively better than expressive language. By 3.6 years of age receptive and expressive language same level. Marked drooling and limited inventory and sequencing at 18 months, yet skills on Kaufman & VMPAC in average range at 3 years, 9 months. Discharged from therapy

Language assessment at 1.1 year, 3 years and 3.6 years. Kaufman test or observations at 1.6, 3 and 3.9 years. VMPAC at 3 years, 9 months

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable regarding prosody and drooling. No statistical analysis.
No blinding of assessors. No replication across participants. Limited repeated measures on same instrument. Participant had multiple therapies concurrently

Vashdi 2013

1 male aged 14 years with severe CAS and limb/motor apraxia and obsessive compulsive disorder

Not quasi‐/RCT (Case study)

Verbal Motor Learning (with Dynamic Distal Stabilization Technique (DDST))

Motor

1 × 30‐minute clinic session and 6 × home practice sessions a week for 4 weeks

(1) Producing highest pitch using /I/ sound with and without DDST, to determine minimum and maximum frequency and length using Speech Analyser 1.5

(2) Imitation of 18 words to analyse word length, maximum loudness, maximum and minimum frequency

Significant t‐test results for (1) increase in maximum frequency and length of pitch after DDST, no change in minimum frequency, and (2) decrease in word length (word said faster), maximum loudness, and maximum frequency

Pre‐ and post‐ treatment

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.
No blinding of assessors. No follow‐up or generalisation data. No replication across participants. Unclear data analysis procedures (unclear if they used visual analysis or perceptual analysis, and if they tested assumptions for the statistical analysis completed)

Vashdi 2014

1 female aged 10 years with CAS and ASD

Not quasi‐/RCT (Case study)

Verbal Motor Learning (Initial Phoneme Cue (IPC) technique)

Motor

2 × 1 hour sessions, 2 weeks apart (participant had initial therapy: 1‐hour session weekly for 1 year prior to this study)

Imitation accuracy of CVCV treated words either (a) with IPC or (b) without IPC

Imitation of CVCV was 0% to 22% accuracy and imitation with IPC was 96% to 100% accuracy

Pre‐ and post‐ treatment

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures. No statistical analysis. No blinding of assessors. No follow‐up or generalisation data. No replication across participants

Yoss 1974

10 children (no information on gender reported) aged 6 to 11 years with moderate to severe DAS

Not quasi‐/RCT (Case descriptions/file audit)

School‐based intervention

Motor

25 to 307 hours of therapy

Articulation, polysyllable words and connected speech in speech samples. Intelligibility rated on a 9‐point scale

Significant improvement on articulation. Minimal generalisation to polysyllable words and connected speech. Intelligibility improved by at least 0.5 points

Pre‐ and post‐ treatment

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis.
No blinding of assessors. No follow‐up data

Zaretsky 2010

1 female aged 11.6 years with CAS, intellectual disability and language disorder

Not quasi‐/RCT (Single case design)

Phonological awareness (phoneme‒grapheme mapping, reading comprehension, 'Basics' programme). Speech ‐ PROMPT and Moving Across Syllables

Linguistic

Between 6.0 and 11.6 ongoing weekly treatments ‐ 1 hour × 1:1 sessions and PROMPT institute over summer

Per cent accuracy on phonological awareness and decoding

Improvement seen in phoneme‒grapheme mapping, segmentation and short vowel identification. Some improvement in decoding

Ongoing 1 × per week sessions from 6.0 to 11.6 years

Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.
No blinding of assessors. No follow‐up or generalisation data. No replication across participants. Difficult to replicate measures and treatment used

Participants: All participants are English speakers unless otherwise reported.

AOS: apraxia of speech; BBTOP: Bankson‐Bernthal Test of Phonology; CAS: childhood apraxia of speech; CSIP: consonant substitute inconsistency percentage; DAS: developmental apraxia of speech; DEAP: Diagnostic Evaluation of Articulation and Phonology; DVD: developmental verbal dyspraxia; GDD: global developmental delay; GFTA‐2: Goldman Fristoe Test of Articulation 2; HCAPP: Hodson Computerized Analysis of Phonological Patterns; ISP: inconsistency severity percentage; KLPA‐2: Khan‐Lewis Phonological Analysis, Second Edition; NARA: Neale Analysis of Reading Ability; PCC: percentage consonants correct; PDD‐NOS: pervasive developmental disorder ‐ not otherwise specified; PMLU: phonological mean length of utterance; PVC: percentage vowels correct; PWC: percentage words correct; PWP: proportion of whole‐word proximity; PIPA: Preschool and Primary Inventory of Phonological Awareness; RCT: randomised control trial; SSD: speech sound disorder; TOCS+: Test of Children's Speech Plus; TOPA: Test of Phonological Awareness; VMPAC: Verbal Motor Production Assessment for Children

Figuras y tablas -
Table 1. Excluded, low‐quality evidence from observational studies (case‐series, case control)